Drugs / AR201
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04056299 Comparator | Aug 2019 → Dec 2020 | — | Aimmune Therapeutics, Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AR201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04056299 ↗ |
| Route | Oral | “oral desensitization immunotherapy (CODIT™) regimen” NCT04056299 ↗ |